25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension - Is it worth the "hype"?

Erin D. Michos; Pamela L. Lutsey

doi:10.1016/j.atherosclerosis.2015.11.035

25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension - Is it worth the "hype"?

Erin D. Michos, Pamela L. Lutsey

Epidemiology

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	237-239
Number of pages	3
Journal	Atherosclerosis
Volume	245
DOIs	https://doi.org/10.1016/j.atherosclerosis.2015.11.035
State	Published - Feb 1 2016

Keywords

Commentary
Coronary heart disease
Hypertension
Risk reclassification
Vitamin D

Access

10.1016/j.atherosclerosis.2015.11.035

Cite this

@article{4ca881fbcfba4564bd759f11087c75a3,

title = "25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension - Is it worth the {"}hype{"}?",

keywords = "Commentary, Coronary heart disease, Hypertension, Risk reclassification, Vitamin D",

author = "Michos, {Erin D.} and Lutsey, {Pamela L.}",

year = "2016",

month = feb,

day = "1",

doi = "10.1016/j.atherosclerosis.2015.11.035",

language = "English (US)",

volume = "245",

pages = "237--239",

journal = "Atherosclerosis",